Senator and former Democratic presidential candidate Bernie Sanders speaks at the Democratic National Convention in Philadelphia, Pennsylvania, U.S. July 25, 2016. REUTERS/Mike Segar - RTSJMKQ (Reuters)

Bernie Sanders is on a mission to make Ariad the new Mylan

Sanders, whose tweet caused Ariad to lose $387 million, is now demanding the drugmaker justify its price increases

Matthew Rozsa
October 22, 2016 12:20AM (UTC)

Sen. Bernie Sanders (I-VT) joined Rep. Elijah Cummings (D-MD) in demanding that Araid Pharmaceuticals justify their recent price increases on leukemia medication.

Iclusig, the drug in question, has had its cost raised four times in 2016 alone. Its annual cost is now almost $200,000 annually, leadings Sanders and Cummings to write “these outrageous sales tactics indicate that Ariad is more concerned with its profit than with its patients.” The two lawmakers plan on investigating whether Ariad tweaks pill dosages and quantities in order to charge patients and insurers more money even while providing less medication. “In the interest of patients and taxpayers, we are interested in learning more about the impact that the escalating price and restrictions on product availability have had," Sanders and Cummings wrote in a public letter to the company.


This isn’t the first time this week that Sanders has put Ariad in the news in an unflattering light. On Sunday, Sanders sent out a tweet criticizing Ariad that caused them to lose $387 million in the stock market. Drug corporations' greed is unbelievable,” Sanders wrote. “Ariad has raised the price of a leukemia drug to almost $199,000 a year.”

The Ariad scandal is reminiscent of a similar controversy earlier this year from Mylan, another pharmaceutical company. First it came out in August that Mylan had increased the cost of EpiPens by roughly 450 percent, making them cost approximately $600. Then in September Mylan CEO Heather Bresch had to appear before Congress, during which she turned in what was widely regarded as a terrible performance while she was harshly criticized by the attending lawmakers. In response to this, Hillary Clinton released a plan to prevent excessive increases in prescription drug prices, including creating a team of federal officials to protect consumers’ interests, imposing fines and other penalties on drug companies that are discovered gouging prices, and expanding access to treatment.

Matthew Rozsa

Matthew Rozsa is a staff writer for Salon. He holds an MA in History from Rutgers University-Newark and is ABD in his PhD program in History at Lehigh University. His work has appeared in Mic, Quartz and MSNBC.

MORE FROM Matthew Rozsa

Related Topics ------------------------------------------

Ariad Pharmaceuticals Bernie Sanders Big Pharma Drug Costs Mylan Prescription Drugs Rep. Elijah Cummings

Fearless journalism
in your inbox every day

Sign up for our free newsletter

• • •